A phase II study of erlotinib (E) in previously untreated elderly patients (pts) with inoperable or advanced stage non-small cell lung cancer (NSCLC) cancer and an ECOG PS 0–3
2008 ◽
Vol 26
(15_suppl)
◽
pp. 19098-19098
Keyword(s):
Phase Ii
◽